Current EASL clinical practice guidelines recommend that patients presenting with AKI 1b or higher receive albumin for two consecutive days (1 g/kg body weight up to a maximum of 100 g per day) (Figure 2). The gene discussed is ALB; the disease is acute kidney injury.